The years 2014/201548 were the first following implementation of other eligibility criteria that defined co-infection with TB, Hepatitis B, cancer, and HTLV as criteria for starting ART, regardless of WHO stage or CD4 cell count (Supplementary Table S1). This evidence concerns the gene CD4 and hepatitis B virus infection.